Advanced ovarian dysgerminoma with cure of tumor persistent in meninges

Christopher J. Jolles, Sharon Karayianis, David Smotkin, Julian E. DeLia

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Isolated meningeal recurrence of ovarian cancer is uncommon. It is generally assumed that such cases are not accompanied by prolonged survival. We report the cure of a patient with advanced ovarian dysgerminoma who developed febrile carcinomatous meningitis 2 weeks after receiving her fifth course of combination chemotherapy (5 months after initiation of chemotherapy). No parenchymal brain disease was identified. The persistence of disease in the leptomeninges is related to the ability of the blood-brain barrier to exclude chemotherapeutic agents. The patient responded to craniospinal radiation and remains free of disease 2 years after completion of treatment.

Original languageEnglish (US)
Pages (from-to)389-391
Number of pages3
JournalGynecologic Oncology
Volume33
Issue number3
DOIs
StatePublished - 1989
Externally publishedYes

Fingerprint

Dysgerminoma
Meninges
Meningeal Carcinomatosis
Brain Diseases
Combination Drug Therapy
Blood-Brain Barrier
Ovarian Neoplasms
Neoplasms
Fever
Radiation
Recurrence
Drug Therapy
Survival
Therapeutics

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Advanced ovarian dysgerminoma with cure of tumor persistent in meninges. / Jolles, Christopher J.; Karayianis, Sharon; Smotkin, David; DeLia, Julian E.

In: Gynecologic Oncology, Vol. 33, No. 3, 1989, p. 389-391.

Research output: Contribution to journalArticle

Jolles, Christopher J. ; Karayianis, Sharon ; Smotkin, David ; DeLia, Julian E. / Advanced ovarian dysgerminoma with cure of tumor persistent in meninges. In: Gynecologic Oncology. 1989 ; Vol. 33, No. 3. pp. 389-391.
@article{8379a75f30244b159f4ce3e6187b85c8,
title = "Advanced ovarian dysgerminoma with cure of tumor persistent in meninges",
abstract = "Isolated meningeal recurrence of ovarian cancer is uncommon. It is generally assumed that such cases are not accompanied by prolonged survival. We report the cure of a patient with advanced ovarian dysgerminoma who developed febrile carcinomatous meningitis 2 weeks after receiving her fifth course of combination chemotherapy (5 months after initiation of chemotherapy). No parenchymal brain disease was identified. The persistence of disease in the leptomeninges is related to the ability of the blood-brain barrier to exclude chemotherapeutic agents. The patient responded to craniospinal radiation and remains free of disease 2 years after completion of treatment.",
author = "Jolles, {Christopher J.} and Sharon Karayianis and David Smotkin and DeLia, {Julian E.}",
year = "1989",
doi = "10.1016/0090-8258(89)90535-0",
language = "English (US)",
volume = "33",
pages = "389--391",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Advanced ovarian dysgerminoma with cure of tumor persistent in meninges

AU - Jolles, Christopher J.

AU - Karayianis, Sharon

AU - Smotkin, David

AU - DeLia, Julian E.

PY - 1989

Y1 - 1989

N2 - Isolated meningeal recurrence of ovarian cancer is uncommon. It is generally assumed that such cases are not accompanied by prolonged survival. We report the cure of a patient with advanced ovarian dysgerminoma who developed febrile carcinomatous meningitis 2 weeks after receiving her fifth course of combination chemotherapy (5 months after initiation of chemotherapy). No parenchymal brain disease was identified. The persistence of disease in the leptomeninges is related to the ability of the blood-brain barrier to exclude chemotherapeutic agents. The patient responded to craniospinal radiation and remains free of disease 2 years after completion of treatment.

AB - Isolated meningeal recurrence of ovarian cancer is uncommon. It is generally assumed that such cases are not accompanied by prolonged survival. We report the cure of a patient with advanced ovarian dysgerminoma who developed febrile carcinomatous meningitis 2 weeks after receiving her fifth course of combination chemotherapy (5 months after initiation of chemotherapy). No parenchymal brain disease was identified. The persistence of disease in the leptomeninges is related to the ability of the blood-brain barrier to exclude chemotherapeutic agents. The patient responded to craniospinal radiation and remains free of disease 2 years after completion of treatment.

UR - http://www.scopus.com/inward/record.url?scp=0024374931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024374931&partnerID=8YFLogxK

U2 - 10.1016/0090-8258(89)90535-0

DO - 10.1016/0090-8258(89)90535-0

M3 - Article

C2 - 2722068

AN - SCOPUS:0024374931

VL - 33

SP - 389

EP - 391

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -